Doubts on Suicide-Anti-Smoking Drug, Pfizer Inc.'s (JOBS) Chantix

Bookmark and Share

Reuters Health -- Despite earlier health agency warnings, there is no strong evidence that the anti-smoking drug Chantix raises the risk of suicidal thoughts or depression compared to other stop-smoking products, researchers reported Thursday in the British Medical Journal.

MORE ON THIS TOPIC